Stock listing
NASDAQ:BLSM BlossomHill Therapeutics, Inc. Stock
Home listing (NASDAQ) of BlossomHill Therapeutics, Inc.
Follow BlossomHill Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BLSM
$12.42 USD -1.33 (-9.7%)
Close on Nov 2, 2026
- Day range
- $12.28 – $14.23 USDNov 2, 2026
- Volume
- 140,741 sharesNov 2, 2026
- Market cap
- $394.8M USDAt the close on Nov 2, 2026 · price × 31.78M shares outstanding
- Traded on an average day
- $4.13M USDMedian day 169,750 shares · 1 day with no trades · last 3 months, Aug 6, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BLSM · Home | $12.42 USD | -1.33 (-9.7%) | 140,741 | $13.80 | $14.23 | $12.28 | $13.75 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 2, 2026 · NASDAQ:BLSM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.42 | -1.33 | -9.7% | $13.80 | $14.23 | $12.28 | 140,741 | |
| $13.75 | -1.46 | -9.6% | $16.40 | $16.40 | $13.51 | 155,794 | |
| $15.21 | -1.25 | -7.6% | $17.00 | $17.53 | $14.90 | 98,955 | |
| $16.46 | +0.705 | +4.5% | $15.83 | $16.63 | $15.67 | 73,512 | |
| $15.76 | -0.635 | -3.9% | $16.34 | $16.94 | $15.61 | 74,206 | |
| $16.39 | +1.76 | +12.0% | $14.53 | $16.82 | $14.53 | 204,367 | |
| $14.63 | -1.18 | -7.5% | $15.82 | $15.82 | $14.42 | 84,346 | |
| $15.81 | +0.21 | +1.3% | $15.47 | $16.71 | $15.47 | 97,971 | |
| $15.60 | +1.20 | +8.3% | $14.54 | $15.68 | $14.47 | 76,269 | |
| $14.40 | +0.24 | +1.7% | $14.09 | $15.05 | $14.09 | 74,924 | |
| $14.16 | +0.22 | +1.6% | $14.10 | $14.25 | $12.93 | 189,368 | |
| $13.94 | -1.04 | -6.9% | $14.79 | $14.79 | $13.31 | 293,100 | |
| $14.98 | -0.28 | -1.8% | $15.17 | $15.53 | $14.70 | 176,500 | |
| $15.26 | -0.22 | -1.4% | $15.39 | $15.84 | $14.77 | 170,200 | |
| $15.48 | -1.79 | -10.4% | $17.25 | $17.91 | $15.35 | 118,600 | |
| $17.27 | -0.21 | -1.2% | $17.40 | $18.22 | $16.93 | 91,100 | |
| $17.48 | +0.60 | +3.6% | $16.80 | $17.77 | $16.68 | 131,800 | |
| $16.88 | +0.27 | +1.6% | $16.52 | $17.28 | $16.18 | 165,200 | |
| $16.61 | -0.68 | -3.9% | $17.17 | $17.67 | $16.12 | 253,800 | |
| $17.29 | -2.65 | -13.3% | $20.06 | $20.06 | $17.06 | 247,400 | |
| $19.94 | +0.25 | +1.3% | $19.72 | $20.11 | $19.06 | 201,500 | |
| $19.69 | +1.10 | +5.9% | $18.33 | $19.86 | $18.27 | 169,300 | |
| $18.59 | -0.05 | -0.3% | $18.49 | $19.74 | $18.46 | 152,600 | |
| $18.64 | -2.73 | -12.8% | $21.24 | $21.24 | $18.41 | 362,200 | |
| $21.37 | +0.03 | +0.1% | $21.17 | $22.20 | $20.70 | 228,500 | |
| $21.34 | +1.59 | +8.1% | $19.51 | $21.55 | $19.01 | 146,400 | |
| $19.75 | -0.72 | -3.5% | $20.46 | $21.03 | $19.33 | 203,100 | |
| $20.47 | -1.87 | -8.4% | $22.42 | $22.63 | $20.21 | 263,500 | |
| $22.34 | -2.91 | -11.5% | $25.30 | $25.81 | $21.88 | 219,400 | |
| $25.25 | -1.55 | -5.8% | $26.37 | $27.31 | $25.03 | 246,900 | |
| $26.80 | +1.06 | +4.1% | $26.09 | $27.99 | $25.12 | 292,200 | |
| $25.74 | -1.08 | -4.0% | $26.80 | $27.55 | $25.41 | 715,100 | |
| $26.82 | +0.57 | +2.2% | $26.49 | $27.80 | $25.61 | 247,600 | |
| $26.25 | +4.08 | +18.4% | $22.34 | $27.11 | $22.01 | 319,800 | |
| $22.17 | +0.43 | +2.0% | $22.50 | $23.38 | $21.71 | 148,800 | |
| $21.74 | +0.88 | +4.2% | $20.90 | $22.08 | $20.45 | 254,300 | |
| $20.86 | -0.65 | -3.0% | $21.55 | $21.90 | $20.75 | 148,900 | |
| $21.51 | -0.49 | -2.2% | $22.00 | $22.39 | $20.68 | 158,900 | |
| $22.00 | -0.93 | -4.1% | $23.00 | $23.29 | $21.82 | 136,300 | |
| $22.93 | +0.92 | +4.2% | $22.05 | $23.37 | $22.00 | 229,200 | |
| $22.01 | +1.99 | +9.9% | $20.00 | $22.16 | $19.36 | 168,700 | |
| $20.02 | +0.64 | +3.3% | $20.31 | $20.59 | $19.39 | 97,300 | |
| $19.38 | +0.39 | +2.1% | $19.10 | $19.91 | $18.84 | 109,700 | |
| $18.99 | +0.69 | +3.8% | $18.60 | $19.93 | $17.98 | 141,200 | |
| $18.30 | -1.26 | -6.4% | $19.57 | $19.57 | $17.59 | 101,600 | |
| $19.56 | -0.24 | -1.2% | $19.82 | $20.61 | $19.44 | 163,600 | |
| $19.80 | +1.34 | +7.3% | $18.25 | $19.84 | $18.25 | 102,400 | |
| $18.46 | +0.04 | +0.2% | $18.58 | $18.63 | $17.96 | 55,700 | |
| $18.42 | +2.39 | +14.9% | $16.10 | $18.80 | $16.10 | 193,500 | |
| $16.03 | -0.35 | -2.1% | $16.38 | $16.50 | $15.94 | 156,000 | |
| $16.38 | +0.58 | +3.7% | $16.00 | $16.50 | $15.75 | 111,400 | |
| $15.80 | -0.37 | -2.3% | $16.21 | $16.27 | $15.60 | 212,000 | |
| $16.17 | +0.07 | +0.4% | $16.21 | $16.77 | $16.01 | 192,800 | |
| $16.10 | -0.28 | -1.7% | $16.58 | $16.73 | $15.96 | 308,100 | |
| $16.38 | +0.20 | +1.2% | $16.14 | $16.42 | $16.00 | 190,700 | |
| $16.18 | -0.17 | -1.0% | $16.31 | $16.76 | $16.00 | 324,000 | |
| $16.35 | +0.11 | +0.7% | $16.32 | $16.89 | $16.22 | 425,800 | |
| $16.24 | -0.28 | -1.7% | $16.52 | $16.88 | $16.17 | 424,200 | |
| $16.52 | +0.53 | +3.3% | $16.39 | $16.98 | $16.15 | 328,500 | |
| $15.99 | -0.01 | -0.1% | $16.50 | $17.25 | $15.97 | 418,300 | |
| $16.00 | 0.00 | 0.0% | $15.75 | $16.05 | $15.25 | 1,757,600 | |
| $16.00 | — | — | $16.00 | $16.00 | $16.00 | 0 |
- Ticker
- NASDAQ:BLSM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
Latest deck · Sep 14, 2026
WCLC 2026
Conference · 8 slides
Latest news
BlossomHill Therapeutics Announces Collaboration with Foundation Medicine to Develop First Companion Diagnostic for BH-30643 in EGFR C797S Mutated Non-Small Cell Lung Cancer
Oct 22, 2026
Closed $15.81 (+1.3%) on Oct 22, 2026
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
Sep 18, 2026
Closed $25.74 (-4.0%) on Sep 18, 2026
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $20.02 (+3.3%) on Sep 3, 2026
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer
Sep 1, 2026
Closed $18.99 (+3.8%) on Sep 1, 2026
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
Aug 19, 2026
Closed $16.17 (+0.4%) on Aug 19, 2026
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
Aug 6, 2026
Closed $16.00 (0.0%) on Aug 7, 2026
Financings
Public offering of common stock
Sep 18, 2026
Closed: US$168.3M raised · US$16 a share · J.P. Morgan +4
Dealers: J.P. Morgan (lead), Leerink Partners (lead), Guggenheim Securities (lead), LifeSci Capital (co-lead), H.C. Wainwright & Co. (co-lead)
Decks
WCLC 2026
Conference · 8 slides · Sep 14, 2026
ASCO 2026
Conference · 11 slides · Sep 9, 2026
Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
J.P. Morgan 2026 Healthcare Conference
Conference · 25 slides · January 2026
BlossomHill Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 8 in all · newest Nov 3, 2026 · oldest 2026
- Decks
- 5 decks · latest Sep 14, 2026
Where BlossomHill Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BLSM · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BLSM | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about BlossomHill Therapeutics, Inc.